uniQure Files for US Approval of Its Huntington’s Gene Therapy and Asks Regulators for Faster Review

uniQure filed for FDA approval of AMT-130, a one-time Huntington’s gene therapy, and requested priority review. Here is what it means.

Have A Referral?